News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
McLoughlin Dennis
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/07/2023 |
4
| McLoughlin Dennis (Chief Customer Officer) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Sold 1,014 shares
@ $38.991, valued at
$39.5k
Sold 1,057 shares
@ $37.865, valued at
$40k
|
|
| 06/07/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/06/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2021 |
4
| McLoughlin Dennis (Chief Customer Officer) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Granted 6,000 shares
@ $0
Granted 15,000 options to buy
@ $60.96, valued at
$914.4k
|
|
| 06/08/2021 |
4
| McLoughlin Dennis (Chief Customer Officer) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Sold 1,895 shares
@ $61.037, valued at
$115.7k
|
|
| 06/11/2020 |
4
| McLoughlin Dennis (Chief Commercial Officer) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Granted 14,000 shares
@ $0
Granted 35,000 options to buy
@ $47.65, valued at
$1.7M
|
|
| 06/08/2020 |
4
| McLoughlin Dennis (Chief Commercial Officer) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Sold 1,447 shares
@ $46.331, valued at
$67k
|
|
| 12/18/2019 |
4
| McLoughlin Dennis (Chief Commercial Officer) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Sold 3,671 shares
@ $45.7935, valued at
$168.1k
|
|
| 06/06/2019 |
4
| McLoughlin Dennis (Chief Commercial Officer) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Sold 1,099 shares
@ $42.91, valued at
$47.2k
Granted 5,600 shares
@ $0
Granted 33,800 options to buy
@ $43.54, valued at
$1.5M
|
|
| 09/07/2018 |
4
| McLoughlin Dennis (Chief Commercial Officer) has filed a Form 4 on Pacira Pharmaceuticals, Inc.|
Txns:
| Exercised 20,000 options to buy
@ $46.55, valued at
$931k
|
|
| 09/07/2018 |
3
| McLoughlin Dennis (Chief Commercial Officer) has filed a Form 3 on Pacira Pharmaceuticals, Inc. |
|
|